YB Financial Statements & Analysis
Complete financial statements for YB including income statement, balance sheet, and cash flow statement. Analyze YB's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
33.1% ↑
Net Income
46.9% ↑
Gross Margin
0.3% ↑
Operating Margin
13.7% ↑
Balance Sheet
Current Ratio
37.8% ↑
Debt to Equity
120.2% ↓
Asset Turnover
-20.5% ↓
Cash Flow
Operating Cash Flow
23.8% ↑
Net Cash Flow
-199.0% ↓
Free Cash Flow
22.6% ↑
Cash Flow to Debt
199.4% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 3.28B | 4.37B | 33.1% | |
| Gross Profit | 3.12B | 4.16B | 33.6% | |
| Operating Income | 858.61M | 1.30B | 51.4% | |
| Net Income | 865.85M | 1.27B | 46.9% | |
| EPS | 115.24 | 55.73 | 51.6% | |
| EBITDA | 873.55M | 1.34B | 53.4% | |
| Gross Margin | 94.94% | 95.23% | 0.3% | |
| Operating Margin | 26.14% | 29.73% | 13.7% | |
| Net Income Margin | 26.36% | 29.08% | 10.3% | |
| R&D Expenses | 231.04M | 365.11M | 58.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.37B | 3.28B | 2.05B | — | — |
| Gross Profit | 4.16B | 3.12B | 1.91B | — | — |
| Operating Income | 1.30B | 858.61M | 175.36M | — | — |
| Net Income | 1.27B | 865.85M | 203.12M | — | — |
| EPS | 55.73 | 115.24 | -44.33 | — | — |
| EBITDA | 1.34B | 873.55M | 191.50M | — | — |
| Gross Margin | 95.23% | 94.94% | 93.25% | — | — |
| Operating Margin | 29.73% | 26.14% | 8.57% | — | — |
| Net Income Margin | 29.08% | 26.36% | 9.93% | — | — |
| R&D Expenses | 365.11M | 231.04M | 128.53M | — | — |
Financial Metrics
Want to dive deeper into YB's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics